Mov Disord 20:6972 Lehnerer SM, Fietzek UM, Messner M, Ceballos-Baumann AO (2014) Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation
Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
Patients considering Mounjaro should discuss with their GP or diabetes specialist whether this therapy is appropriate for their individual circumstances, taking into account their treatment history, comorbidities, and personal preferences
In addition to its primary weight loss benefits, semaglutide may offer secondary advantages for overall health
You should speak with a provider before considering BPC-157 if you: Have a chronic medical condition Take prescription medications Have immune system concerns Have a history of cancer Are pregnant or breastfeeding Are recovering from surgery Have ongoing pain or unexplained inflammation Are using other peptides, hormones, or performance compounds BPC-157 should not replace proper diagnosis, imaging, rehab, or medical treatment for injuries